SNNLive caught up with Thomas Equels, CEO AIM ImmunoTech Inc. (NYSE American: AIM), via Zoom to discuss (Click the time stamp to jump to each answer, or watch it all): 0:26 Filing of Provisional Patent Application for the Use of…
SNNLive caught up with Thomas Equels, CEO AIM ImmunoTech Inc. (NYSE American: AIM), via Zoom to discuss (Click the time stamp to jump to each answer, or watch it all): 0:26 Filing of Provisional Patent Application for the Use of…
Johns Hopkins researchers have received $35 million in funding from the U.S. Department of Defense for two nationwide clinical trials totaling 1,100 people to test the effectiveness of outpatient treatment of convalescent blood plasma, which is a transfusion of a…
In the race to be the first, Russia says it’s close to finding an effective vaccine, and that distribution could start as early as this fall. But the country’s small trial size is raising eyebrows. BREAKING NEWS UPDATES: ABC News…
The Logical Indian’s Shubham Thakur explains everything about clinical trials and latest developments of the Oxford University’s Coronavirus Vaccine. There have been some positive developments in the Covid-19 vaccine race as per the study. #Coronavirus #CoronavirusVaccine #OxfordCoronaVaccine #ShubhamThakurExplains